Eosinophilia means an increased absolute eosinophil count (AEC) in peripheral blood, usually >500 cells/µL.
| Severity | AEC |
|---|
| Mild | 500-1,500/µL |
| Moderate | 1,500-5,000/µL |
| Severe | >5,000/µL |
Eosinophils are white blood cells involved in allergic inflammation and defense against helminth parasites. - The Washington Manual of Medical Therapeutics, p. 428
Common causes
- Allergic or atopic disease: asthma, allergic rhinitis, eczema, urticaria.
- Drug reactions: antibiotics such as penicillins/cephalosporins or sulfonamides, NSAIDs, anticonvulsants, and others. Severe drug reactions such as DRESS can cause eosinophilia with fever, rash, hepatitis, nephritis, or lung disease.
- Parasitic infection, especially tissue-invasive helminths: Strongyloides, hookworm, schistosomiasis, filariasis, toxocariasis, trichinellosis.
- Autoimmune/inflammatory disorders: eosinophilic granulomatosis with polyangiitis and some connective-tissue diseases.
- Endocrine disease: particularly adrenal insufficiency (Addison disease).
- Cancer or clonal hematologic disease: Hodgkin lymphoma, T-cell lymphoma, myeloproliferative neoplasms, chronic eosinophilic leukemia.
- Idiopathic eosinophilia: considered only after primary and secondary causes are excluded.
Hypereosinophilic syndrome
Consider hypereosinophilic syndrome (HES) if AEC is ≥1,500/µL on repeated testing, no secondary cause is found, and there is evidence of eosinophil-related organ injury. It may affect the heart, lungs, nervous system, skin, gastrointestinal tract, or kidneys. Cardiac disease is especially important. - The Washington Manual of Medical Therapeutics, p. 428
Evaluation
The approach depends on the clinical context:
- Repeat CBC with differential and calculate the AEC, not just the eosinophil percentage.
- Review all medicines, supplements, and recent new drugs.
- Ask about asthma/allergy symptoms, rash, fever, weight loss, travel, exposure to soil or contaminated food/water, and pet/contact history.
- Directed tests may include peripheral smear, liver/kidney tests, stool or parasite testing, Strongyloides serology, chest imaging, IgE, and hematology testing if persistent or marked.
- For persistent unexplained moderate-to-severe eosinophilia, assess for organ involvement, sometimes including ECG/echocardiography and specialist evaluation.
Do
not start systemic corticosteroids without considering
Strongyloides in someone with relevant tropical/subtropical exposure, because steroids can trigger life-threatening disseminated infection. The
Merck Manual review also advises cause-directed testing and treatment.
When urgent assessment is needed
Seek prompt medical review for eosinophilia with chest pain, breathlessness, fainting, new neurologic symptoms, severe rash or facial swelling, high fever, jaundice, abdominal pain, rapidly rising AEC, or AEC ≥1,500/µL that persists.
Treatment is of the
underlying cause. Mild, asymptomatic eosinophilia may only need repeat monitoring. Recent review evidence includes a pediatric diagnostic-algorithm systematic review (
PMID 38695861); adult assessment still relies mainly on clinical context and ruling out reactive, drug-related, parasitic, and clonal causes.